Prostacyclin is a member of the family of lipid molecules known as eicosanoids. When given as a drug it is known as epoprostenol. (Dorlands)  It is produced in endothelial cells from prostaglandin H₂ (PGH₂) by the action of the enzyme prostacyclin synthase. Although prostacyclin is considered an independent mediator, it is called PGI₂ (prostaglandin I₂) in eicosanoid nomenclature, and is a member of the prostanoids (together with the prostaglandins and thromboxane).

The series-3 prostaglandin PGH₃ also follows the prostacyclin synthase pathway, yielding another prostacyclin, PGI₃.(Fischer, 1985)  The unqualified term 'prostacyclin' usually refers to PGI₂. PGI₂ is derived from the ω-6 arachidonic acid. PGI₃ is derived from the ω-3 EPA.

Mode of action

---

Prostacyclin acts chiefly to prevent platelet formation and clumping involved in blood clotting. It is also an effective vasodilator. Prostacyclin's interactions in contrast to thromboxane, another eicosanoid, strongly suggest a mechanism of cardiovascular homeostasis between the two hormones in relation to vascular damage.

More on [ Prostacyclin ]

Epoprostenol - Twitter Search

...dalteparina, diltiazem, furozemida, metolazona, hidralazina, bosentana, sitaxsentan, ambrisentan, sildanefil, epoprostenol, iloprost...
staziaki (Pedro Staziaki) Thu, 17 Dec 2009 16:39:06 -0000
...dalteparina, diltiazem, furozemida, metolazona, hidralazina, bosentana, sitaxsentan, ambrisentan, sildanefil, epoprostenol, iloprost...

Subscribe to Epoprostenol RSS feed